FDA to Hold Listening Session as Part of Broader Work to Optimize Use of, and Processes for, Advisory Committees

Today, the U.S. Food and Drug Administration announced it will host a listening session in June as part of its broader work to optimize the use of, and processes for, advisory committees. This virtual public meeting will focus on the composition of advisory committees, ways to improve the experience for members serving on committees and ways to ensure public awareness and understanding of the role of FDA advisory committees. Advisory committees are typically made up of technical, scientific, public health and medical experts, as well as representatives of industry, consumer organizations and patients. They provide the FDA with independent advice on many topics, including the development, use...